Last reviewed 2026-05-22 · How we verify

Zzowin Nutra Tablet

NovoBliss Research Pvt Ltd · Phase 1 active Small molecule ✓ Verified May 2026 Quality 0/100

Zzowin Nutra Tablet is a Small molecule drug developed by NovoBliss Research Pvt Ltd. It is currently in Phase 1 development. Also known as: Herbal Supplement.

Zzowin Nutra Tablet is a small molecule that acts as a glucocorticoid receptor agonist. It is being studied in a clinical trial for its safety and effectiveness in treating difficulty in sleep initiation.

Likelihood of approval

9.6% vs 9.6% industry baseline

If approved by FDA: likely 2033–2036

Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 1 → approval rate +9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2033–2036	—
EMA	EU	2034–2037	+0.7 yr
MHRA	GB	2034–2037	+0.7 yr
Health Canada	CA	2034–2038	+0.9 yr
TGA	AU	2034–2038	+1.2 yr
PMDA	JP	2034–2038	+1.5 yr
NMPA	CN	2035–2039	+2.3 yr
MFDS	KR	2034–2038	+1.4 yr
CDSCO	IN	2034–2039	+1.8 yr
ANVISA	BR	2035–2039	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	Zzowin Nutra Tablet
Also known as	Herbal Supplement
Sponsor	NovoBliss Research Pvt Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Clinical Study to Assess the Safety and Effectiveness of Herbal Supplement in Adult Human Subjects. (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Zzowin Nutra Tablet CI brief — competitive landscape report
Zzowin Nutra Tablet updates RSS · CI watch RSS
NovoBliss Research Pvt Ltd portfolio CI

Frequently asked questions about Zzowin Nutra Tablet

What is Zzowin Nutra Tablet?

Zzowin Nutra Tablet is a Small molecule drug developed by NovoBliss Research Pvt Ltd.

Who makes Zzowin Nutra Tablet?

Zzowin Nutra Tablet is developed by NovoBliss Research Pvt Ltd (see full NovoBliss Research Pvt Ltd pipeline at /company/novobliss-research-pvt-ltd).

Is Zzowin Nutra Tablet also known as anything else?

Zzowin Nutra Tablet is also known as Herbal Supplement.

What development phase is Zzowin Nutra Tablet in?

Zzowin Nutra Tablet is in Phase 1.

Manufacturer: NovoBliss Research Pvt Ltd — full pipeline
Also known as: Herbal Supplement

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing